MTHFD2 and acute myeloid leukemia: In malignant hematopoiesis, Pikman et al. demonstrated that the knockdown of MTHFD2 in acute myeloid leukemia (AML) cells restrained cell growth, colony formation, and promoted differentiation, resulting in decreased leukemia burden and prolonged survival of AML mouse models [15].